Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-28 Purchase | 2026-09-30 4:01 pm | Phio Pharmaceuticals Corp. | PHIO | Plott Ronald Todd Director | 10,000 | $1.035 | $10,350 | 42,000 (Direct) | View |
| 2026-09-24 Purchase | 2026-09-25 4:01 pm | Phio Pharmaceuticals Corp. | PHIO | BRADFORD PATRICIA A Director | 6,500 | $1.0127 | $6,583 | 64,151 (Direct) | View |
| 2026-09-22 Purchase | 2026-09-23 4:01 pm | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres. & CEO | 2,000 | $1.0289 | $2,058 | 364,871 (Direct) | View |
| 2026-09-15 Purchase | 2026-09-16 4:01 pm | Phio Pharmaceuticals Corp. | PHIO | BRADFORD PATRICIA A Director | 12,000 | $1.03 | $12,360 | 57,651 (Direct) | View |
| 2026-08-19 Purchase | 2026-08-20 08:30 am | Phio Pharmaceuticals Corp. | PHIO | Plott Ronald Todd Director | 15,000 | $1.14 | $17,100 | 15,000 (Direct) | View |
| 2026-08-18 Purchase | 2026-08-19 4:01 pm | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres. & CEO | 10,000 | $1.06 | $10,600 | 431,421 (Direct) | View |
| 2026-06-26 Purchase | 2026-06-29 4:02 pm | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres. & CEO | 10,000 | $0.99 | $9,900 | 421,421 (Direct) | View |
| 2025-12-31 Purchase | 2026-01-02 4:05 pm | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres. & CEO | 5,000 | $1.03 | $5,150 | 291,421 (Direct) | View |
| 2025-12-23 Purchase | 2025-12-29 08:10 am | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres. & CEO | 5,000 | $1.02 | $5,100 | 286,421 (Direct) | View |
| 2025-11-21 Purchase | 2025-11-24 12:54 pm | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres. & CEO | 5,000 | $1.14 | $5,700 | 281,421 (Direct) | View |
| 2025-11-18 Purchase | 2025-11-19 12:47 pm | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres. & CEO | 5,000 | $1.27 | $6,350 | 276,421 (Direct) | View |
| 2025-06-10 Purchase | 2025-06-11 5:00 pm | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres & CEO | 2,000 | $2.42 | $4,840 | 27,149 (Direct) | View |
| 2025-06-10 Purchase | 2025-06-11 4:59 pm | Phio Pharmaceuticals Corp. | PHIO | Ferrara Robert L Director | 2,500 | $2.4199 | $6,050 | 15,666 (Direct) | View |
| 2025-06-09 Purchase | 2025-06-10 4:43 pm | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres & CEO | 1,500 | $2.75 | $4,125 | 25,149 (Direct) | View |
| 2025-05-21 Purchase | 2025-05-23 09:04 am | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres & CEO | 4,200 | $1.7728 | $7,446 | 23,649 (Direct) | View |
| 2025-05-20 Purchase | 2025-05-21 4:13 pm | Phio Pharmaceuticals Corp. | PHIO | Ferrara Robert L Director | 2,500 | $1.82 | $4,550 | 13,166 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-28 Option Award | 2026-09-29 4:01 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Carson Lisa Cabott Chief Financial Officer | 108,000 | $0 | 189,112 (Direct) | View |
| 2026-09-28 Option Award | 2026-09-29 4:01 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres. & CEO | 400,000 | $0 | 764,871 (Direct) | View |
| 2026-09-28 Option Award | 2026-09-29 4:01 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Plott Ronald Todd Director | 17,000 | $0 | 32,000 (Direct) | View |
| 2026-09-11 Tax Withholding | 2026-09-15 4:00 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Carson Lisa Cabott Chief Financial Officer | 12,888 | $1.03 | 81,112 (Direct) | View |
| 2026-09-11 Tax Withholding | 2026-09-15 4:00 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres. & CEO | 68,550 | $1.03 | 362,871 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-06 08:01 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Lockshin Curtis Director | 16,600 | $0 | 35,155 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-06 08:00 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Freeman Jonathan E Director | 16,600 | $0 | 32,655 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-06 07:59 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Deming David H Director | 23,800 | $0 | 37,800 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-06 07:58 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Carson Lisa Cabott Chief Financial Officer | 47,000 | $0 | 94,000 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-06 07:57 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | BRADFORD PATRICIA A Director | 18,500 | $0 | 45,651 (Direct) | View |
| 2026-02-05 Option Award | 2026-02-06 07:56 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres. & CEO | 120,000 | $0 | 411,421 (Direct) | View |
| 2025-09-11 Option Award(A) | 2025-09-15 4:02 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Ferrara Robert L Director | 23,100 | $0 | 38,766 (Direct) | View |
| 2025-09-11 Option Award | 2025-09-15 08:30 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Deming David H Director | 14,000 | $0 | 14,000 (Direct) | View |
| 2025-09-11 Option Award | 2025-09-15 08:29 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Lockshin Curtis Director | 16,200 | $0 | 18,555 (Direct) | View |
| 2025-09-11 Option Award | 2025-09-15 08:29 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Freeman Jonathan E Director | 14,700 | $0 | 16,055 (Direct) | View |
| 2025-09-11 Option Award | 2025-09-15 08:29 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Ferrara Robert L Director | 23,000 | $0 | 38,666 (Direct) | View |
| 2025-09-11 Option Award | 2025-09-15 08:28 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Carson Lisa Cabott VP, Finance and Administration | 47,000 | $0 | 47,000 (Direct) | View |
| 2025-09-11 Option Award | 2025-09-15 08:28 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | BRADFORD PATRICIA A Director | 18,800 | $0 | 27,151 (Direct) | View |
| 2025-09-11 Option Award | 2025-09-15 08:28 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres. & CEO | 250,000 | $0 | 271,421 (Direct) | View |
| 2025-09-11 Tax Withholding | 2025-09-15 08:28 am | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Bitterman Robert J Chairman, Pres. & CEO | 4,111 | $2.32 | 271,421 (Direct) | View |
| 2024-09-11 Option Award | 2024-09-13 3:00 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Infarinato Robert M. VP, CFO | 3,000 | $0 | 11,000 (Direct) | View |
| 2024-09-11 Option Award | 2024-09-13 2:59 pm | N/A N/A | Phio Pharmaceuticals Corp. | PHIO | Freeman Jonathan E Director | 1,000 | $0 | 1,000 (Direct) | View |